drugset
drugset / Trial / NCT01299220

Study of Acitretin to Treat Skin Rash Caused by Erlotinib (a Chemotherapy Drug)

NCT01299220 ↗

Phase 4 Withdrawn University of Pittsburgh OSI Pharmaceuticals · collab
NaSingle-groupOpen-labelTreatment

Summary

This study will look at if a low-dose regimen of acitretin is helpful in treating a skin rash caused by the chemotherapy drug, erlotinib.

Timeline

Start
2010-11
Primary completion
2011-09
Completion
2011-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Acitretin Small molecule 10 mg Oral

Indications

exanthem